Cardiologist providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Chiropractor providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Dentist providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Dermatologist providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Family Physician providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
OB-GYN providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Ophthalmologist providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Orthopedic Surgeon providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Pediatrician providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Physical Therapist providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Podiatrist providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Psychiatrist providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Jeffrey Pakula, DO, FACC, is board-certified in internal medicine and cardiology. He provides a wide range of cardiology services at Cardiac Care Consultants in Peoria, and Sun City West, Arizona. Dr. Pakula has been practicing medicine in Arizona since 1997 and joined Cardiac Care Consultants in 2001. He specializes in coronary artery disease and heart failure.
Dr. Pakula received his medical degree from Kansas City University in Missouri. He completed his internal medicine training at the University of Illinois and received his cardiology fellowship at the University of Health Sciences at the Chicago Medical School in Illinois. After completing his fellowship, he served as the Director of Medical Education at John H. Stroger Jr. Hospital of Cook County in Chicago, Illinois.
Dr. Pakula welcomes both new and existing patients to Cardiac Care Consultants and is excited to be a part of their health care journey. To schedule an appointment with Dr. Pakula, call the office or book a consultation online
Vijay Swarup, MD, FACC, FHRS, is one of the physicians at Arizona Heart Rhythm Center, which has locations in Phoenix, Peoria, Gilbert, and Prescott, Arizona. He has been practicing clinical cardiac electrophysiology in Arizona since 2002. Before joining the practice, he completed a fellowship in clinical cardiac electrophysiology at the University of Chicago Hospitals and Loyola University Medical Center in Chicago, Illinois.
Dr. Swarup earned his bachelor's and medical degrees at the University of Delhi in New Delhi. He continued his education at St. Louis University School of Medicine, completing an internal medicine residency and a research fellowship in molecular cardiology. He completed a Cardiovascular Disease fellowship at the Thomas Jefferson University Hospital in Philadelphia. He then pursued a clinical cardiac electrophysiology fellowship at the University of Chicago Hospitals and Loyola University Medical Center in Chicago, Illinois.
Dr. Swarup has received specialized training in performing complex arrhythmia treatments, including trans-catheter ablations. He has a special interest in three-dimensional electroanatomical mapping techniques, left atrial appendage occlusion techniques, and ablative therapies for atrial fibrillation and ventricular tachycardia.
In Arizona, Dr. Swarup was among the first to perform epicardial and endocardial 3D mapping guided ablation of ischemic ventricular tachycardias, open irrigated ablations, robotic catheter ablations for arrhythmias, and implantation to left atrial appendage occlusion devices. Dr. Swarup has some of the most extensive experience in AF and VT ablations and implantation of LAA occlusion devices in the country. Dr. Swarup is also an active researcher of new ablation techniques, having authored numerous abstracts and manuscripts. He has been the principal investigator in many research protocols investigating promising new ablation techniques and devices for the treatment of arrhythmias.
Dr. Swarup is board certified in cardiovascular diseases and clinical cardiac electrophysiology.
Dr. Ertz-Archambault is triple board-certified in Hematology, Medical Oncology, and Internal Medicine, dedicated to providing expert and compassionate care to patients facing blood disorders and cancers, with a special emphasis in breast cancer. Dr. Ertz-Archambault has dedicated her career to serving the Phoenix cancer community. She spent over four years caring for the underserved cancer population at Valleywise Health, where she partnered with the breast cancer team honored with The Spirit of Healing Award from the Cancer Support Community of Arizona in 2022. Her commitment extends beyond the clinic through volunteer work, charity educational programs, and quality improvement initiatives for underserved cancer patients. Dr Ertz-Archambault is an active member of the American Society of Clinical Oncology and the American Society of Hematology. She also serves as an Assistant Clinical Professor at Creighton University, Phoenix School of Medicine, mentoring the next generation of physicians. Outside of medicine, she enjoys painting, gardening, and spending time with her family
Dr. Nagaiah received his medical degree from MGR Medical University in India and has been in practice for more than 20 years. His residency and internship were completed at Mercy Catholic Medical Center in Pennsylvania, and he completed a fellowship at West Virginia University. He earned a Masters in Clinical Research from the MGH Institute of Health Professions in Boston. Dr. Nagaiah has expertise in treating lymphoma, lung cancer, and breast cancer, among other conditions.
PHILOSOPHY
I believe that being an oncologist is a privilege that is not to be taken lightly. I strive to provide evidence-based care that is appropriate to my patients’ particular problem, recognizing and respecting individual patient’s wishes. I take a multidisciplinary approach to care, including alternative therapies that have been shown to be effective.
RESEARCH PUBLICATIONS
Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol.2011;2011:542358. 2. Batalo M, Nagaiah G, Abraham J. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther.2011;11(8):1277-1282. 3. Nagaiah G, Remick SC. Combretastatin A4 phosphate: A novel vascular disrupting agent. Future Oncol. 2010;6(8):1219-1228 4. Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233-240. 5. Nagaiah G, Almubarak M, Khan M, Altaha R. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: Report of two cases and review of literature. Cancer Invest. 2010;28(10):1048-1053
Dr. Laeth George grew up in the Phoenix Metro area before completing his undergraduate studies at the University of Arizona in Tucson, Arizona, earning a Bachelor’s degree with Honors in Physiology. He obtained his M.D. from the University of Arizona College of Medicine – Phoenix, where he met his wife. Following this, he completed Internal Medicine residency at Case Western Reserve University Hospitals in Cleveland, Ohio. Thereafter, he completed his fellowship in Hematology and Oncology at the Cleveland Clinic Foundation – Taussig Cancer Center in Cleveland, Ohio.
During these years of training, he published multiple peer-reviewed articles in various medical journals regarding diseases like multiple myeloma as well as kidney cancer. He has presented research at national meetings, including at the 2023 Genitourinary Oncology meeting of the American Society of Clinical Oncology (ASCO).
He is excited to return to Phoenix and help serve the community he and his family consider to be home. He has a strong dedication to the care of patients with Hematologic and Oncologic conditions, and has experience treating a broad spectrum of both common and rare disorders in Hematology and Oncology. He believes in partnering with patients and their loved ones to provide compassionate, holistic, and evidence-based care to achieve the best outcomes possible.
Outside of work, he enjoys spending time with his wife and family, reading, trying new restaurants, and is an avid sports fan.
Dr. Ertz-Archambault is triple board-certified in Hematology, Medical Oncology, and Internal Medicine, dedicated to providing expert and compassionate care to patients facing blood disorders and cancers, with a special emphasis in breast cancer. Dr. Ertz-Archambault has dedicated her career to serving the Phoenix cancer community. She spent over four years caring for the underserved cancer population at Valleywise Health, where she partnered with the breast cancer team honored with The Spirit of Healing Award from the Cancer Support Community of Arizona in 2022. Her commitment extends beyond the clinic through volunteer work, charity educational programs, and quality improvement initiatives for underserved cancer patients. Dr Ertz-Archambault is an active member of the American Society of Clinical Oncology and the American Society of Hematology. She also serves as an Assistant Clinical Professor at Creighton University, Phoenix School of Medicine, mentoring the next generation of physicians. Outside of medicine, she enjoys painting, gardening, and spending time with her family
Dr. Nagaiah received his medical degree from MGR Medical University in India and has been in practice for more than 20 years. His residency and internship were completed at Mercy Catholic Medical Center in Pennsylvania, and he completed a fellowship at West Virginia University. He earned a Masters in Clinical Research from the MGH Institute of Health Professions in Boston. Dr. Nagaiah has expertise in treating lymphoma, lung cancer, and breast cancer, among other conditions.
PHILOSOPHY
I believe that being an oncologist is a privilege that is not to be taken lightly. I strive to provide evidence-based care that is appropriate to my patients’ particular problem, recognizing and respecting individual patient’s wishes. I take a multidisciplinary approach to care, including alternative therapies that have been shown to be effective.
RESEARCH PUBLICATIONS
Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol.2011;2011:542358. 2. Batalo M, Nagaiah G, Abraham J. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther.2011;11(8):1277-1282. 3. Nagaiah G, Remick SC. Combretastatin A4 phosphate: A novel vascular disrupting agent. Future Oncol. 2010;6(8):1219-1228 4. Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233-240. 5. Nagaiah G, Almubarak M, Khan M, Altaha R. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: Report of two cases and review of literature. Cancer Invest. 2010;28(10):1048-1053
Dr. Laeth George grew up in the Phoenix Metro area before completing his undergraduate studies at the University of Arizona in Tucson, Arizona, earning a Bachelor’s degree with Honors in Physiology. He obtained his M.D. from the University of Arizona College of Medicine – Phoenix, where he met his wife. Following this, he completed Internal Medicine residency at Case Western Reserve University Hospitals in Cleveland, Ohio. Thereafter, he completed his fellowship in Hematology and Oncology at the Cleveland Clinic Foundation – Taussig Cancer Center in Cleveland, Ohio.
During these years of training, he published multiple peer-reviewed articles in various medical journals regarding diseases like multiple myeloma as well as kidney cancer. He has presented research at national meetings, including at the 2023 Genitourinary Oncology meeting of the American Society of Clinical Oncology (ASCO).
He is excited to return to Phoenix and help serve the community he and his family consider to be home. He has a strong dedication to the care of patients with Hematologic and Oncologic conditions, and has experience treating a broad spectrum of both common and rare disorders in Hematology and Oncology. He believes in partnering with patients and their loved ones to provide compassionate, holistic, and evidence-based care to achieve the best outcomes possible.
Outside of work, he enjoys spending time with his wife and family, reading, trying new restaurants, and is an avid sports fan.
Leon Thompson, DO, is an experienced internal medicine physician at Thompson Medical Group in Peoria, Arizona. He provides comprehensive care to adults of all ages living with conditions ranging from heart disease and diabetes to memory loss. He supports people with personalized chronic disease management and weight management programs.
Dr. Thompson is a native of Arizona. He attended St. Matthew Catholic School in Phoenix, Arizona, and graduated from St. Mary’s Catholic High School, also in Phoenix. Dr. Thompson completed his undergraduate studies at Arizona State University in Phoenix and attended medical school at the Western University of Health Sciences, College of Osteopathic Medicine of the Pacific in Pomona, California.
After graduating with a Doctorate in Osteopathic Medicine, Dr. Thompson completed his internship and residency at St. Joseph’s Hospital and Medical Center in Phoenix, Arizona. He completed an American College of Osteopathic Internists fellowship and is board-certified in internal medicine.
Dr. Thompson welcomes patients to Thompson Medical Group, where they can be sure of outstanding care delivered in a professional and respectful environment.
Dr. Laeth George grew up in the Phoenix Metro area before completing his undergraduate studies at the University of Arizona in Tucson, Arizona, earning a Bachelor’s degree with Honors in Physiology. He obtained his M.D. from the University of Arizona College of Medicine – Phoenix, where he met his wife. Following this, he completed Internal Medicine residency at Case Western Reserve University Hospitals in Cleveland, Ohio. Thereafter, he completed his fellowship in Hematology and Oncology at the Cleveland Clinic Foundation – Taussig Cancer Center in Cleveland, Ohio.
During these years of training, he published multiple peer-reviewed articles in various medical journals regarding diseases like multiple myeloma as well as kidney cancer. He has presented research at national meetings, including at the 2023 Genitourinary Oncology meeting of the American Society of Clinical Oncology (ASCO).
He is excited to return to Phoenix and help serve the community he and his family consider to be home. He has a strong dedication to the care of patients with Hematologic and Oncologic conditions, and has experience treating a broad spectrum of both common and rare disorders in Hematology and Oncology. He believes in partnering with patients and their loved ones to provide compassionate, holistic, and evidence-based care to achieve the best outcomes possible.
Outside of work, he enjoys spending time with his wife and family, reading, trying new restaurants, and is an avid sports fan.
Dr. Nagaiah received his medical degree from MGR Medical University in India and has been in practice for more than 20 years. His residency and internship were completed at Mercy Catholic Medical Center in Pennsylvania, and he completed a fellowship at West Virginia University. He earned a Masters in Clinical Research from the MGH Institute of Health Professions in Boston. Dr. Nagaiah has expertise in treating lymphoma, lung cancer, and breast cancer, among other conditions.
PHILOSOPHY
I believe that being an oncologist is a privilege that is not to be taken lightly. I strive to provide evidence-based care that is appropriate to my patients’ particular problem, recognizing and respecting individual patient’s wishes. I take a multidisciplinary approach to care, including alternative therapies that have been shown to be effective.
RESEARCH PUBLICATIONS
Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol.2011;2011:542358. 2. Batalo M, Nagaiah G, Abraham J. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther.2011;11(8):1277-1282. 3. Nagaiah G, Remick SC. Combretastatin A4 phosphate: A novel vascular disrupting agent. Future Oncol. 2010;6(8):1219-1228 4. Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233-240. 5. Nagaiah G, Almubarak M, Khan M, Altaha R. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: Report of two cases and review of literature. Cancer Invest. 2010;28(10):1048-1053
Dr. Ertz-Archambault is triple board-certified in Hematology, Medical Oncology, and Internal Medicine, dedicated to providing expert and compassionate care to patients facing blood disorders and cancers, with a special emphasis in breast cancer. Dr. Ertz-Archambault has dedicated her career to serving the Phoenix cancer community. She spent over four years caring for the underserved cancer population at Valleywise Health, where she partnered with the breast cancer team honored with The Spirit of Healing Award from the Cancer Support Community of Arizona in 2022. Her commitment extends beyond the clinic through volunteer work, charity educational programs, and quality improvement initiatives for underserved cancer patients. Dr Ertz-Archambault is an active member of the American Society of Clinical Oncology and the American Society of Hematology. She also serves as an Assistant Clinical Professor at Creighton University, Phoenix School of Medicine, mentoring the next generation of physicians. Outside of medicine, she enjoys painting, gardening, and spending time with her family
Teodor Pitea, MD, is a board-certified gastroenterologist and founder of Interventional Endoscopy Associates PLLC in Peoria, Scottsdale, and Phoenix, Arizona.
Dr. Pitea received his medical degree from Iuliu Hațieganu University of Medicine and Pharmacy in Cluj-Napoca, Romania, before moving to the United States in 2001 to pursue a career in gastroenterology. Following a residency in internal medicine, he completed a fellowship in gastroenterology at Mount Sinai Morningside (formerly St. Luke’s-Roosevelt Hospital Center), an affiliate of Columbia University Vagelos College of Physicians and Surgeons. During that time, he also completed a postdoctoral research fellowship on the role of insulin resistance in patients with metabolic syndrome and trained for six months as a hepatology fellow in the Liver Transplant Program at Mount Sinai Hospital. As a gastroenterology fellow, Dr. Pitea discovered his passion for endoscopy, which led him to pursue further training in advanced therapeutic endoscopy under the mentorship of Dr. Stavros Stavropoulos, one of the pioneers of endoscopic surgery, at Winthrop University Hospital in Long Island, New York.
In September 2012, Dr. Pitea launched the Interventional Endoscopy Service at Banner Del E. Webb Medical Center in Sun City West, Arizona. Over the next four years, he spearheaded the building of a new endoscopy unit and developed a highly trained medical team dedicated to interventional endoscopy. Dr. Pitea joined the Digestive Institute at Banner-University Medical Center Phoenix in 2016, and together with Rawad Mounzer, MD, he established the Interventional Endoscopy Service there in collaboration with University of Arizona faculty.
During his role as the Director of Endoscopy and Chief of the Advanced Endoscopy Program, he developed a comprehensive program for the management of acute and chronic pancreatitis, and he has continued to advance the field of endoscopic surgery in Arizona by providing complex, cutting-edge endoscopic interventions.
Dr. Pitea has published multiple abstracts and has been an invited speaker at national conferences. He is a diplomat of the American Board of Internal Medicine as well as the American Board of Gastroenterology.
Dr. Ertz-Archambault is triple board-certified in Hematology, Medical Oncology, and Internal Medicine, dedicated to providing expert and compassionate care to patients facing blood disorders and cancers, with a special emphasis in breast cancer. Dr. Ertz-Archambault has dedicated her career to serving the Phoenix cancer community. She spent over four years caring for the underserved cancer population at Valleywise Health, where she partnered with the breast cancer team honored with The Spirit of Healing Award from the Cancer Support Community of Arizona in 2022. Her commitment extends beyond the clinic through volunteer work, charity educational programs, and quality improvement initiatives for underserved cancer patients. Dr Ertz-Archambault is an active member of the American Society of Clinical Oncology and the American Society of Hematology. She also serves as an Assistant Clinical Professor at Creighton University, Phoenix School of Medicine, mentoring the next generation of physicians. Outside of medicine, she enjoys painting, gardening, and spending time with her family
Dr. Nagaiah received his medical degree from MGR Medical University in India and has been in practice for more than 20 years. His residency and internship were completed at Mercy Catholic Medical Center in Pennsylvania, and he completed a fellowship at West Virginia University. He earned a Masters in Clinical Research from the MGH Institute of Health Professions in Boston. Dr. Nagaiah has expertise in treating lymphoma, lung cancer, and breast cancer, among other conditions.
PHILOSOPHY
I believe that being an oncologist is a privilege that is not to be taken lightly. I strive to provide evidence-based care that is appropriate to my patients’ particular problem, recognizing and respecting individual patient’s wishes. I take a multidisciplinary approach to care, including alternative therapies that have been shown to be effective.
RESEARCH PUBLICATIONS
Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol.2011;2011:542358. 2. Batalo M, Nagaiah G, Abraham J. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther.2011;11(8):1277-1282. 3. Nagaiah G, Remick SC. Combretastatin A4 phosphate: A novel vascular disrupting agent. Future Oncol. 2010;6(8):1219-1228 4. Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233-240. 5. Nagaiah G, Almubarak M, Khan M, Altaha R. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: Report of two cases and review of literature. Cancer Invest. 2010;28(10):1048-1053
Dr. Laeth George grew up in the Phoenix Metro area before completing his undergraduate studies at the University of Arizona in Tucson, Arizona, earning a Bachelor’s degree with Honors in Physiology. He obtained his M.D. from the University of Arizona College of Medicine – Phoenix, where he met his wife. Following this, he completed Internal Medicine residency at Case Western Reserve University Hospitals in Cleveland, Ohio. Thereafter, he completed his fellowship in Hematology and Oncology at the Cleveland Clinic Foundation – Taussig Cancer Center in Cleveland, Ohio.
During these years of training, he published multiple peer-reviewed articles in various medical journals regarding diseases like multiple myeloma as well as kidney cancer. He has presented research at national meetings, including at the 2023 Genitourinary Oncology meeting of the American Society of Clinical Oncology (ASCO).
He is excited to return to Phoenix and help serve the community he and his family consider to be home. He has a strong dedication to the care of patients with Hematologic and Oncologic conditions, and has experience treating a broad spectrum of both common and rare disorders in Hematology and Oncology. He believes in partnering with patients and their loved ones to provide compassionate, holistic, and evidence-based care to achieve the best outcomes possible.
Outside of work, he enjoys spending time with his wife and family, reading, trying new restaurants, and is an avid sports fan.
Dr. Nagaiah received his medical degree from MGR Medical University in India and has been in practice for more than 20 years. His residency and internship were completed at Mercy Catholic Medical Center in Pennsylvania, and he completed a fellowship at West Virginia University. He earned a Masters in Clinical Research from the MGH Institute of Health Professions in Boston. Dr. Nagaiah has expertise in treating lymphoma, lung cancer, and breast cancer, among other conditions.
PHILOSOPHY
I believe that being an oncologist is a privilege that is not to be taken lightly. I strive to provide evidence-based care that is appropriate to my patients’ particular problem, recognizing and respecting individual patient’s wishes. I take a multidisciplinary approach to care, including alternative therapies that have been shown to be effective.
RESEARCH PUBLICATIONS
Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol.2011;2011:542358. 2. Batalo M, Nagaiah G, Abraham J. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther.2011;11(8):1277-1282. 3. Nagaiah G, Remick SC. Combretastatin A4 phosphate: A novel vascular disrupting agent. Future Oncol. 2010;6(8):1219-1228 4. Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233-240. 5. Nagaiah G, Almubarak M, Khan M, Altaha R. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: Report of two cases and review of literature. Cancer Invest. 2010;28(10):1048-1053
/assets/images/provider/photos/2377432.jpg)
/assets/images/provider/photos/2377432.jpg)
/assets/images/provider/photos/2288383.jpg)
/assets/images/provider/photos/2288383.jpg)